Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.36 AUD | -7.69% |
|
+20.00% | +105.71% |
Jun. 26 | Cleo Diagnostics Secures US FDA Feedback for Ovarian Cancer Test | MT |
Jun. 23 | 7,500,000 Ordinary Shares of Cleo Diagnostics Ltd are subject to a Lock-Up Agreement Ending on 23-JUN-2024. | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CLEO DIAGNOSTICS LTD | Diagnostic & Testing Substances | -7.69% | +20.00% | +105.71% | - | - | 33.36M | ![]() | ![]() | ![]() |
- Stock Market
- Equities
- COV Stock
- Charts Cleo Diagnostics Ltd
- Relative Strength Chart